Genovese, Mark C. http://orcid.org/0000-0001-5294-4503
Burmester, Gerd R.
Hagino, Owen
Thangavelu, Karthinathan
Iglesias-Rodriguez, Melitza
John, Gregory St
González-Gay, Miguel A.
Mandrup-Poulsen, Thomas
Fleischmann, Roy
Funding for this research was provided by:
Sanofi Genzyme
Regeneron Pharmaceuticals
Article History
Received: 2 August 2019
Accepted: 2 June 2020
First Online: 9 September 2020
Ethics approval and consent to participate
: Protocols for all trials were approved by the appropriate ethics committees/institutional review boards, and each patient provided written informed consent before participation in their study. The studies were conducted in compliance with institutional review board regulations, the International Conference on Harmonisation Guidelines for Good Clinical Practice and the Declaration of Helsinki.
: Not applicable.
: MCG has received research grants and consulting fees or other remuneration (payment) from Sanofi Genzyme, Genentech, Roche and R-Pharm.GRB has received research grants from AbbVie, Pfizer, UCB and Roche and has received consulting fees or other remuneration (payment) or participated in speakers’ bureaus from/for AbbVie, Lilly, Merck Sharp & Dohme, Pfizer, Roche, Sanofi and UCB.TM-P has received consulting fees from Sanofi.OH, MI-R and KT are employees of Sanofi Genzyme and may hold stock and/or stock options in the company.GSJ is an employee of Regeneron Pharmaceuticals, Inc. and may hold stock and/or stock options in the company.MAG-G has received research grants and consulting fees from AbbVie, Roche, Sanofi, Eli Lilly and Novartis.RF has received research grants from AbbVie, Acea, Amgen, Bristol-Myers Squibb, Celgene, Celltrion, Genentech, Eli Lilly, GlaxoSmithKline, Pfizer, Roche, Sanofi and UCB and has received consulting fees from AbbVie, Akros Pharma, Amgen, Bristol-Myers Squibb, Eli Lilly, Pfizer, Samsung, Taiho and UCB.